Impact of Clindamycin on the Oral-Gut Axis: Gastrointestinal Side Effects and Clostridium difficile Infection in 45 Patients
Elizabeth Litvinov, Alan Litvinov · 2024
Read Impact of Clindamycin on the Oral-Gut Axis: Gastrointestinal Side Effects and Clostridium difficile Infection in 45 Patients by Elizabeth Litvinov, Alan Litvinov (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710861.txt.
Description
Elizabeth Litvinov and Alan Litvinov compared in 2024 the gut side effects of two doses of the antibiotic clindamycin in forty-five patients. The drug works well against bacteria but often upsets the gut, and severe gut infection can follow. Patients took either a 300 or a 600 milligram dose for seven to ten days. The pair tracked stomach upset, diarrhea length, pain, and recovery time.
Nearly every patient, ninety-eight percent, reported some side effect. The higher dose caused more frequent and stronger effects: diarrhea lasted five days on average, against three at the lower dose. The study sits within a wider account of how the drug disturbs the mouth-to-gut pathway. The authors argue dose choice should weigh gut harm alongside cure.
Catalog record
| CREATOR | Elizabeth Litvinov, Alan Litvinov |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |